✅ Suggested content. Review the technical data and compliance, adjust whatever you need and delete this line before publishing.
Tirzepatide is a peptide that acts as a dual agonist of two hormone receptors: GIP and GLP-1, both linked to metabolic regulation. It is one of the most studied molecules in the metabolic area today. At NeoPeptidos it is offered as research-grade material, with ≥99% HPLC purity and exclusively for research.
Technical profile
| Product | Tirzepatide |
|---|---|
| CAS | 2023788-19-2 |
| Molecular formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular weight | 4813.45 Da |
| Sequence | Doble agonista GIP/GLP-1 (39 aa) |
| Purity | 99% HPLC |
| Presentation | Lyophilized vial; bacteriostatic water included |
| Use | For scientific research use only |
What is Tirzepatide?
GIP and GLP-1 are incretin hormones that take part in glucose and appetite signaling. Tirzepatide is a single 39-amino-acid peptide designed to activate both receptors at once, which distinguishes it from agonists acting on a single receptor. Because of that mechanism it is classified as a dual incretin agonist.
Research context
Tirzepatide is the subject of extensive scientific research in the metabolic field, particularly on glucose homeostasis and body weight regulation in preclinical and clinical studies.
The NeoPeptidos product is research-grade material, not a clinical medicine dispensed by NeoPeptidos; it includes no indications or administration schedules and is intended exclusively for researchers.
Handling and reconstitution
See the reconstitution guide and the storage guide.
Quality and traceability
≥99% purity by HPLC and batch COA. See quality control.
🔬 Updated on June 8, 2026 · Reviewed by the NeoPeptidos team · Content for research purposes (RUO).